Skip to main content
. Author manuscript; available in PMC: 2016 Jun 5.
Published in final edited form as: Chem Biol Interact. 2014 Nov 21;234:154–161. doi: 10.1016/j.cbi.2014.11.010

Figure 5.

Figure 5

Doxorubicinol formation by Gclm −/− and Gclm +/+ liver homogenates. (A) Representative HPLC chromatograms of doxorubicinol formation in Gclm −/− (top panel) and Gclm +/+ (bottom panel) dialyzed liver homogenates. (B) Quantification by HPLC of doxorubicinol formation (area units, AU) in dialyzed liver homogenates following incubation with 50 mM doxorubicin; n=4 per genotype. *indicates p < 0.05 for Student’s t-test relative to wild-type.